Chemoinformaics analysis of BETA-INDOLEACETIC-ACID
| Molecular Weight | 303.318 | nRot | 7 |
| Heavy Atom Molecular Weight | 286.182 | nRig | 13 |
| Exact Molecular Weight | 303.122 | nRing | 2 |
| Solubility: LogS | -1.755 | nHRing | 1 |
| Solubility: LogP | -0.234 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 39 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 22 | No. of Aromatic Carbocycles | 1 |
| nHetero | 7 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 17 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 3 | No. of Arom Atom | 9 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 10 |
| nHA | 3 | APOL | 42.8935 |
| nHD | 4 | BPOL | 20.2285 |
| QED | 0.595 |
| Synth | 2.457 |
| Natural Product Likeliness | -0.248 |
| NR-PPAR-gamma | 0.124 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.057 |
| HIA | 0.25 |
| CACO-2 | -5.577 |
| MDCK | 0.0000216 |
| BBB | 0.506 |
| PPB | 0.456285 |
| VDSS | 0.188 |
| FU | 0.620745 |
| CYP1A2-inh | 0.015 |
| CYP1A2-sub | 0.06 |
| CYP2c19-inh | 0.057 |
| CYP2c19-sub | 0.047 |
| CYP2c9-inh | 0.047 |
| CYP2c9-sub | 0.946 |
| CYP2d6-inh | 0.02 |
| CYP2d6-sub | 0.155 |
| CYP3a4-inh | 0.012 |
| CYP3a4-sub | 0.048 |
| CL | 3.714 |
| T12 | 0.779 |
| hERG | 0.015 |
| Ames | 0.01 |
| ROA | 0.143 |
| SkinSen | 0.158 |
| Carcinogencity | 0.103 |
| EI | 0.012 |
| Respiratory | 0.019 |
| NR-Aromatase | 0.002 |
| Antiviral | Yes |
| Prediction | 0.832649 |